000 01215 a2200337 4500
005 20250517170201.0
264 0 _c20180501
008 201805s 0 0 eng d
022 _a1557-7422
024 7 _a10.1089/hum.2017.021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSiegler, Elizabeth
245 0 0 _aDesigned Ankyrin Repeat Proteins as Her2 Targeting Domains in Chimeric Antigen Receptor-Engineered T Cells.
_h[electronic resource]
260 _bHuman gene therapy
_c09 2017
300 _a726-736 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnkyrin Repeat
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aReceptor, ErbB-2
_xgenetics
650 0 4 _aReceptors, Antigen, T-Cell
_xgenetics
650 0 4 _aRecombinant Fusion Proteins
650 0 4 _aSingle-Chain Antibodies
_xgenetics
650 0 4 _aT-Lymphocytes
_xmetabolism
700 1 _aLi, Si
700 1 _aKim, Yu Jeong
700 1 _aWang, Pin
773 0 _tHuman gene therapy
_gvol. 28
_gno. 9
_gp. 726-736
856 4 0 _uhttps://doi.org/10.1089/hum.2017.021
_zAvailable from publisher's website
999 _c27454124
_d27454124